Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | HRH1 | P35367 | 1/20 | 0.36 |
| ▸ | SLC22A16 | Q86VW1 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | CRAT | P43155 | 1/20 | 0.33 |
| ▸ | CPT2 | P23786 | 1/20 | 0.33 |
| ▸ | CPT1A | P50416 | 1/20 | 0.33 |
| ▸ | GALR3 | O60755 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5157841 | 0.88 | TSHR (0.36) | MEN1KMT2ACYP1A2HRH1SLC22A16 | |
| SCHEMBL8910736 | 0.80 | LAP3 (0.37) | MEN1KMT2ACYP1A2HRH1SLC22A16 | |
| SCHEMBL7950629 | 0.79 | MEN1 (0.31) | MEN1KMT2ACYP1A2HRH1SMN1; SMN2 | |
| SCHEMBL946299 | 0.78 | BTN3A1 (0.30) | — | |
| SCHEMBL1003887 | 0.77 | SLC22A16 (0.31) | SLC22A16TSHRCHRM2CHRM4CHRM1 | |
| SCHEMBL7702001 | 0.74 | TSHR (0.38) | MEN1KMT2ACYP1A2HRH1SLC22A16 | |
| SCHEMBL80350 | 0.71 | THRB (0.36) | MEN1KMT2ACYP1A2HRH1TSHR | |
| SCHEMBL14988988 | 0.70 | TSHR (0.37) | MEN1KMT2ACYP1A2HRH1TSHR | |
| SCHEMBL6276269 | 0.70 | THRB (0.39) | MEN1KMT2ACYP1A2HRH1TSHR | |
| SCHEMBL1260630 | 0.70 | MEN1 (0.33) | MEN1KMT2ACYP1A2HRH1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9750847-B2 | Chitosan hydrogel derivatives as a coating agent with broad spectrum of antimicrobial activities | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2017-09-05 | — | — | US | disclosed |
| US-20160038636-A1 | CHITOSAN HYDROGEL DERIVATIVES AS A COATING AGENT WITH BROAD SPECTRUM OF ANTIMICROBIAL ACTIVITIES | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2016-02-11 | — | — | US | disclosed |
| EP-2454286-B1 | CHITOSAN HYDROGEL DERIVATIVES AS A COATING AGENT WITH BROAD SPECTRUM OF ANTIMICROBIAL ACTIVITIES | MENICON CO LTD (JP) | 2015-12-16 | — | — | EP | disclosed |
| US-9199000-B2 | Chitosan hydrogel derivatives as a coating agent with broad spectrum of antimicrobial activities | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2015-12-01 | — | — | US | disclosed |
| WO-2015065100-A1 | SPHERICAL HYDROGEL PARTICLES USING MPC AND WATER-SOLUBLE CROSSLINKING AGENT | 주식회사 아모레퍼시픽 | 2015-05-07 | — | — | WO | disclosed |
| US-20140193476-A1 | CHITOSAN HYDROGEL DERIVATIVES AS A COATING AGENT WITH BROAD SPECTRUM OF ANTIMICROBIAL ACTIVITIES | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2014-07-10 | — | — | US | disclosed |
| US-8709470-B2 | Chitosan hydrogel derivatives as a coating agent with broad spectrum of antimicrobial activities | MENICON CO., LTD. (JP) | 2014-04-29 | — | — | US | disclosed |
| US-20120164208-A1 | CHITOSAN HYDROGEL DERIVATIVES AS A COATING AGENT WITH BROAD SPECTRUM OF ANTIMICROBIAL ACTIVITIES | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2012-06-28 | — | — | US | disclosed |
| EP-2454286-A1 | CHITOSAN HYDROGEL DERIVATIVES AS A COATING AGENT WITH BROAD SPECTRUM OF ANTIMICROBIAL ACTIVITIES | Menicon Co., Ltd. (JP) | 2012-05-23 | — | — | EP | disclosed |
| US-8097253-B2 | Methods for inhibiting angiogenesis | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2012-01-17 | — | — | US | disclosed |
| US-20070166382-A1 | Bioresponsive polymer system for delivery of microbicides | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2007-07-19 | — | — | US | disclosed |
| EP-1773375-A1 | NETRIN-RELATED COMPOSITIONS AND USES | University of Utah Research Foundation (US) | 2007-04-18 | — | — | EP | disclosed |
| EP-1737500-A1 | BIORESPONSIVE POLYMER SYSTEM FOR DELIVERY OF MICROBICIDES | The University of Utah Research Foundation (US) | 2007-01-03 | — | — | EP | disclosed |
| US-7125837-B1 | biodrugs consisting of proteins having amino acid sequences attached to biocompatible supports or dissolved in matrices having antiproliferative, cell differentiation stimulation, controlling migration and binding of smooth muscle, used for prophylaxis of restenosis | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2006-10-24 | — | — | US | disclosed |
| WO-2006019904-A1 | NETRIN-RELATED COMPOSITIONS AND USES | UNIVERSITY OF UTHA RESEARCH FOUNDATION (US) | 2006-02-23 | — | — | WO | disclosed |
| US-20060019896-A1 | Netrin-related compositions and uses | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2006-01-26 | — | — | US | disclosed |
| US-20050261189-A1 | Methods of promoting cardiac cell proliferation | HYDRA BIOSCIENCES, INC. | 2005-11-24 | — | — | US | disclosed |
| WO-2005097210-A1 | BIORESPONSIVE POLYMER SYSTEM FOR DELIVERY OF MICROBICIDES | THE UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2005-10-20 | — | — | WO | disclosed |
| EP-1175225-A2 | ELASTIN-BASED COMPOSITIONS | The University of Utah Research Foundation (US) | 2002-01-30 | — | — | EP | disclosed |
| WO-2000050068-A2 | ELASTIN-BASED COMPOSITIONS | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2000-08-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160038636-A1 | CHITOSAN HYDROGEL DERIVATIVES AS A COATING AGENT WITH BROAD SPECTRUM OF ANTIMICROBIAL ACTIVITIES | ACMSD, CDC37, USP30 | MEN1 3189/4885KMT2A 2712/4885CYP1A2 2607/4885 |
| US-20050261189-A1 | Methods of promoting cardiac cell proliferation | MKI67, TNNI3, TNNT2 | MEN1 4264/4885KMT2A 2828/4885CYP1A2 4737/4885 |
| US-20140193476-A1 | CHITOSAN HYDROGEL DERIVATIVES AS A COATING AGENT WITH BROAD SPECTRUM OF ANTIMICROBIAL ACTIVITIES | ACMSD, CDC37, USP30 | MEN1 3189/4885KMT2A 2712/4885CYP1A2 2607/4885 |
| US-20120164208-A1 | CHITOSAN HYDROGEL DERIVATIVES AS A COATING AGENT WITH BROAD SPECTRUM OF ANTIMICROBIAL ACTIVITIES | CRYZ, CRYAA, USP30 | MEN1 3263/4885KMT2A 3282/4885CYP1A2 2176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.